Strategic Vendor Oversight and Trial Support for a Pivotal Phase 3 CNS Program

VRMM Stage: Pivotal Inflection
Seuss+ provided integrated vendor oversight and execution support for a small biotech preparing a pivotal Phase 3 in a challenging CNS indication. Its CRO had deep therapeutic insight but limited experience in complex global delivery, and the lean internal team had gaps in oversight, vendor coordination, and contracts. We filled them.

Summary

A small biotech company preparing for a pivotal Phase 3 trial in a challenging CNS indication had selected a CRO with deep therapeutic insight but limited experience in complex global delivery.

The sponsor’s internal team was lean, with functional gaps in oversight, vendor coordination, and contract governance. When COVID-19 introduced added risk, the need for hands-on support became urgent.

Seuss+ was brought in first to review a contract, then rapidly engaged to deliver fully integrated support across the trial lifecycle.

anaveon image 3

I cannot imagine NOT having Seuss+ as part of our business, to be honest. For a scaling company such as ours, there are vendors who can give you every piece. But being able to maintain the relationships and understanding of our company, and provide solutions, is something that Seuss+ excels in.”

Client Representative, Blinded CNS Biotech

ahead on trial enrollment milestone

oversight

on vendor documentation

14
years of hands-on vendor optimization
Seuss+
55+
biotech programs supported
Seuss+
10+
therapeutic areas of expertise
Seuss+

What Seuss+ Delivered

Integrated Execution Support Across Workstreams

We served as an embedded partner across multiple workstreams, reinforcing clinical operations with structure, vendor accountability, and risk governance. Our support aligned tightly with the VRMM framework, ensuring momentum and regulatory confidence from execution to submission.

 

The Risk/Challenge

M

Selected CRO lacked global trial management experience

M

Limited internal capacity for governance, risk, and financial tracking

M

Gaps in oversight between CRO and its subcontractors threatened data quality

M

Trial timelines and communication strained by COVID-19 disruptions

The Results

N

Trial enrollment completed six weeks ahead of milestone target

N

Oversight gap closed, avoided data integrity risk between vendors

N

Operational alignment preserved during high-pressure vendor escalation

N

Client board maintained confidence through clear governance structure

N

Zero findings on vendor documentation during a regulatory inspection

Workstream Deployment Timeline: From Risk Mitigation to Submission Success

Seuss+ blinded clinical trial timeline showing 7 workstreams across 4 years: vendor oversight, risk management, governance

How We Helped

Conducted risk assessment and embedded monthly issue resolution cadence

Facilitated a structured conflict resolution workshop during vendor escalation

Managed quarterly governance meetings, focused on KPIs and delivery health

Implemented budget tracking tools for financial transparency and reporting

Prepared documentation and processes for inspection-readiness

Frequently asked questions

A CRO with deep therapeutic insight but limited complex-global-delivery experience, plus a lean team with oversight and coordination gaps.

Integrated vendor oversight and hands-on execution support, closing the gaps in oversight, coordination, and contracts.

Because it is the highest-stakes moment. Strong oversight keeps a science-strong but delivery-light CRO on track.

Schedule a consultation now

 

Key takeaways

  • The challenge: a pivotal Phase 3 CNS trial with a CRO strong on science but light on complex global delivery.
  • The lean sponsor team had gaps in oversight, vendor coordination, and contracts.
  • Seuss+ provided integrated vendor oversight and execution support through the pivotal inflection stage.

Talk to the Seuss+ team

Book a 30-minute strategic call to see how this fits your trial.

Book an intro call